Search research articles
Contact Us
Filters
Showing results (21-30 of 223) with videos related to
Page
of 23
Sort By:
Biochimica Et Biophysica Acta
|
January 18, 2011
Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS
Linda Henneman, Arno G van Cruchten, Willem Kulik, et al.
European Journal of Human Genetics : EJHG
|
October 23, 2003
Novel mutations in the PEX12 gene of patients with a peroxisome biogenesis disorder
Jeannette Gootjes, Frank Schmohl, Hans R Waterham, et al.
Histochemistry and Cell Biology
|
December 26, 2016
Peroxisomal abnormalities in the immortalized human hepatocyte (IHH) cell line
Femke C C Klouwer, Janet Koster, Sacha Ferdinandusse, et al.
Arthritis and Rheumatism
|
November 1, 2006
A role for geranylgeranylation in interleukin-1beta secretion
Saskia H L Mandey, Loes M Kuijk, Joost Frenkel, et al.
Clinical Dysmorphology
|
January 7, 2003
Midface hypoplasia, obesity, developmental delay and neonatal hypotonia in two brothers
Lieke Rozendaal, Harry Del Canho, Hans R Waterham, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
April 18, 2024
Molecular and cellular consequences of mevalonate kinase deficiency
Frouwkje A Politiek, Marjolein Turkenburg, Linda Henneman, et al.
Human Mutation
|
October 31, 2009
Spectrum of PEX6 mutations in Zellweger syndrome spectrum patients
Merel S Ebberink, Janet Kofster, Ronald J A Wanders, et al.
Human Mutation
|
July 13, 2006
Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency
Saskia H L Mandey, Marit S Schneiders, Janet Koster, et al.
Clinical Rheumatology
|
December 16, 2006
A patient with hyper-IgD syndrome responding to anti-TNF treatment
Erkan Demirkaya, M Kazim Caglar, Hans R Waterham, et al.
Journal of Inherited Metabolic Disease
|
December 22, 2023
Identification of FDA-approved drugs that increase mevalonate kinase in hyper IgD syndrome
Frouwkje A Politiek, Marjolein Turkenburg, Janet Koster, et al.
Page
of 23
Search research articles
Search
Showing results (21-30 of 223) with videos related to
Sort By:
Page
of 23
Biochimica Et Biophysica Acta
|
January 18, 2011
Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS
Linda Henneman, Arno G van Cruchten, Willem Kulik, et al.
European Journal of Human Genetics : EJHG
|
October 23, 2003
Novel mutations in the PEX12 gene of patients with a peroxisome biogenesis disorder
Jeannette Gootjes, Frank Schmohl, Hans R Waterham, et al.
Histochemistry and Cell Biology
|
December 26, 2016
Peroxisomal abnormalities in the immortalized human hepatocyte (IHH) cell line
Femke C C Klouwer, Janet Koster, Sacha Ferdinandusse, et al.
Arthritis and Rheumatism
|
November 1, 2006
A role for geranylgeranylation in interleukin-1beta secretion
Saskia H L Mandey, Loes M Kuijk, Joost Frenkel, et al.
Clinical Dysmorphology
|
January 7, 2003
Midface hypoplasia, obesity, developmental delay and neonatal hypotonia in two brothers
Lieke Rozendaal, Harry Del Canho, Hans R Waterham, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
April 18, 2024
Molecular and cellular consequences of mevalonate kinase deficiency
Frouwkje A Politiek, Marjolein Turkenburg, Linda Henneman, et al.
Human Mutation
|
October 31, 2009
Spectrum of PEX6 mutations in Zellweger syndrome spectrum patients
Merel S Ebberink, Janet Kofster, Ronald J A Wanders, et al.
Human Mutation
|
July 13, 2006
Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency
Saskia H L Mandey, Marit S Schneiders, Janet Koster, et al.
Clinical Rheumatology
|
December 16, 2006
A patient with hyper-IgD syndrome responding to anti-TNF treatment
Erkan Demirkaya, M Kazim Caglar, Hans R Waterham, et al.
Journal of Inherited Metabolic Disease
|
December 22, 2023
Identification of FDA-approved drugs that increase mevalonate kinase in hyper IgD syndrome
Frouwkje A Politiek, Marjolein Turkenburg, Janet Koster, et al.
Page
of 23